Correlation Between Scpharmaceuticals and Nuvalent
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Nuvalent, you can compare the effects of market volatilities on Scpharmaceuticals and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Nuvalent.
Diversification Opportunities for Scpharmaceuticals and Nuvalent
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Scpharmaceuticals and Nuvalent is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Nuvalent go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Nuvalent
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Nuvalent. In addition to that, Scpharmaceuticals is 1.15 times more volatile than Nuvalent. It trades about 0.0 of its total potential returns per unit of risk. Nuvalent is currently generating about 0.09 per unit of volatility. If you would invest 6,708 in Nuvalent on August 25, 2024 and sell it today you would earn a total of 2,785 from holding Nuvalent or generate 41.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Scpharmaceuticals vs. Nuvalent
Performance |
Timeline |
Scpharmaceuticals |
Nuvalent |
Scpharmaceuticals and Nuvalent Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Scpharmaceuticals and Nuvalent
The main advantage of trading using opposite Scpharmaceuticals and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.Scpharmaceuticals vs. Milestone Pharmaceuticals | Scpharmaceuticals vs. Oncolytics Biotech | Scpharmaceuticals vs. Seres Therapeutics | Scpharmaceuticals vs. DiaMedica Therapeutics |
Nuvalent vs. Eliem Therapeutics | Nuvalent vs. HCW Biologics | Nuvalent vs. RenovoRx | Nuvalent vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |